Press and Public Relations

Press and Public Relations

Press Officer and Head of Press and Public Relations

Dr. Stefanie Seltmann

Dr. Stefanie Seltmann
© dkfz.de

Dr. Stefanie Seltmann

Im Neuenheimer Feld 280
69120 Heidelberg

Phone: +49 6221 422854
Fax: +49 6221 422968

E-Mail: s.seltmann@dkfz.de
or presse@dkfz.de

Recent Press Releases

No. 51 | 01. December 2016 | by Koh

DKTK Tübingen: €2.5 million for developing a novel cancer immunotherapy

Tumor cells coated with bispecific antibodies are attacked and killed by ac...
© J.Chiu, G.Jung

Scientists from the German Cancer Consortium (DKTK) at Tübingen University Hospital have developed a promising bispecific antibody for use in immunotherapy of prostate cancer and so-called squamous cell carcinoma, which can occur, for example, in the lungs, skin or uterus. The antibody binds to cancer cells as well as immune cells, thus provoking an immune response against the tumor. The Helmholtz Association now provides €2.5 million from its validation fund for the purpose of executing the next steps in the pharmaceutical development of the bispecific antibody.In the German Cancer Consortium (DKTK), the German Cancer Research Center (DKFZ) in Heidelberg joins up as a core center in long-term collaborations with university institutes and hospitals all over Germany that are specialized in research and treatment with a focus on oncology.

learn more

No. 47 | 21. November 2016 | by ah

30 Years of the Cancer Information Service: More important than ever before!

What patients ask: Breast and prostate cancer are the most asked about.
© dkfz.de

Every year, more and more people are afflicted by cancer. In 2015 there were about 490,000 new cases in Germany alone. So, it is not surprising that the need for reliable information continues to grow: Last year, the German Cancer Information Service (KID) of the German Cancer Research Center (DKFZ) responded to 34,000 individual enquiries from all across Germany – more than ever before. Every month between 450,000 and 635,000 users accessed information on the website www.krebsinformationsdienst.de. Since 2014, doctors, caregivers, therapists and psychological counselors have utilized and valued the professional service krebsinformationsdienst.med.

learn more

No. 46 | 14. November 2016 | by Koh

Research to combat pancreatic cancer

Illustration of the pancreas
© Wellcome Library, London

Cancer of the pancreas is one of the most aggressive types of cancer and therapies currently used are usually rather ineffective. Therefore, scientists at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) in Heidelberg are very committed in the fight against this disease. They discovered what makes this cancer type so resistant against drugs and why the tumors spread outside the pancreas so early. Based on these findings, they are testing schizophrenia medications, novel agents and even viruses in the treatment of pancreatic cancer.

learn more

Audio (in German only)

more

einblick (in German only)

Publications

Videos (in German only)

RSS-Feed

Subscribe to our RSS-Feed.

to top